Evolus
EOLS
#7666
Rank
A$0.65 B
Marketcap
A$9.85
Share price
-6.86%
Change (1 day)
-7.13%
Change (1 year)

Earnings for Evolus (EOLS)

Earnings in 2026 (TTM): -A$43.77 Million

According to Evolus 's latest financial reports the company's current earnings are A$0.32 Billion. In 2025 the company made an earning of -A$77 Million a decrease over its 2024 earnings that were of -A$75.18 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Evolus from 2017 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$43.77 Million-43.16%
2025 -A$77 Million2.43%
2024 -A$75.18 Million-19.11%
2023 -A$92.93 Million-17.23%
2022 -A$0.12 Billion59.02%
2021 -A$70.61 Million-71.32%
2020 -A$0.25 Billion55.09%
2019 -A$0.16 Billion124.48%
2018 -A$70.71 Million298.96%
2017 -A$17.73 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-A$0.24 Billion 414.62%๐Ÿ‡บ๐Ÿ‡ธ USA